Impact of Ig-Therasorb (R) immunoapheresis on stability of xenogeneic ex vivo porcine liver perfusion - Value of aminotransferases and flow rates for the assessment of metabolic graft viability by Kornberg, Arno et al.
Impact of Ig-Therasorb® Immunoapheresis on Stability of Xenogeneic
Ex Vivo Porcine Liver Perfusion – Value of Aminotransferases and 
Flow Rates for the Assessment of Metabolic Graft Viability
Clin Chem Lab Med 2000; 38(11):1187–1190 © 2000 by Walter de Gruyter · Berlin · New York
Arno Kornberg1, Oliver Dietz 2, Henning Mau2,
Johannes Scheele1 and Claus Hammer2
1 Department of General and Visceral Surgery,
Friedrich-Schiller-University of Jena, Jena, Germany
2 Institute for Surgical Research, Klinikum Großhadern,
Ludwig Maximilian University, Munich, Munich, Germany
Due to growing shortage of donor organs, the concept
of extracorporeal pig liver perfusion in the treatment
of acute liver failure has been rediscovered. Im-
munomodulation, such as immunoapheresis or inhibi-
tion of complement, results in long-term perfusion
without exact knowledge of the remaining metabolic
graft viability. This study was aimed at the comparison
of conventional parameters of graft stability such as
perfusion rates and release of aminotransferases with
parameters of metabolic graft function. Ig-Therasorb®
immunoapheresis (IA) of the xenogeneic perfusate
was performed to protect the discordant pig livers
from hyperacute rejection, mediated by preformed
naturally occurring human xenogeneic antibodies. The
application of IA created stable autologous graft reper-
fusion after a short time of xenoperfusion, but it was
not able to prevent the livers from severe synthetic
and functional damage. In the future, improvement of
xenogeneic graft function, rather than pure prolonga-
tion of perfusion, must be the principal aim. 
Key words: Extracorporeal pig liver perfusion; Im-
munoapheresis; Metabolic function.
Abbreviations: ALF, acute liver failure; ECLP, extra-
corporeal pig liver perfusion; GE, galactose-elimina-
tion-rate; GLDH, glutamate dehydrogenase; HXR,
hyperacute xenograft rejection; IA, Ig-Therasorb® im-
munoapheresis; MEGX, monoethylglycinexilidide-test;
THP, total hepatic perfusion; XNAb, xenoreactive natu-
rally preformed antibodies.
Introduction
The dramatic shortage of donor livers has led to a high
mortality of patients awaiting urgent liver grafts. In this
context, extracorporeal pig liver perfusion (ECLP) has
experienced a revival in the 1980’s and 1990’s (1, 2). As
a discordant organ, the porcine liver undergoes hyper-
acute xenograft rejection (HXR) mediated by pre-
formed, naturally occurring, human anti-pig xeno-
geneic antibodies (XNAb) and complement (3, 4).
Immunomodulation of the xenogeneic perfusate re-
sults in a significant prolongation of perfusion periods
but without any indication of the remaining metabolic
graft viability and associated potential benefit for the
patient with acute liver failure (ALF) (5–7). Conven-
tional parameters for determination of xenogeneic
liver function are the release of aminotransferases and
development of perfusion flow rates (1, 2). However
the value of these parameters for evaluation of the liv-
ers’ metabolic capability for detoxification and thus for
the clinical use remains speculative. The aim of this
study was the comparison of conventional parameters
of graft stability with the capability for detoxification
and synthesis of a xenogeneic pig liver using autolo-
gous reperfusion. Ig-Therasorb® immunoapheresis
(IA) of XNAb was performed to delay HXR. The results
are expected to help identifying beneficial graft func-
tion and thus to avoid harmful periods of perfusion for
the patient with ALF.
Materials and Methods
Animals ex vivo perfusion
For ECLP, livers of 18 Landrace pigs (body weight: 25–30 kg)
were carefully explanted after in situ flush with 2000 ml Uni-
versity of Wisconsin solution (0 °C) and collection of autolo-
gous blood. The grafts were normothermic ex vivo perfused
with 1500 ml of fresh human blood (8, 9). Flow rates and vas-
cular pressure were continuously measured online (Labtech,
Spectra Computersystems GmbH, Karlsruhe, Germany). Can-
nulation of the Ductus choledochus permitted determination
of bile production.
Ig-Therasorb® immunoapheresis
To deplete XNAb we used a pyrogen-free Ig-Therasorb® glass
column containing polyclonal sheep anti-human IgG antibod-
ies (heavy and light chain-specificity) conjugated to cyanogen
bromide-activated Sepharose beads (Plasmaselect, Teltow,
Germany). They are able to bind all four subclasses of IgG an-
tibodies as well as IgM and IgA antibodies. By enzyme-linked
immunosorbent assay (ELISA) and nephelometry we could
measure a reduction of IgG, IgM and IgA of 92%, 75% and 78%
respectively, comparable with results already published (7, 8).
Analytical studies
Graft stability was assessed by online measurement of total
hepatic blood flow (THP, sum of portal and arterial flow rates).
The release of the mitochondrial glutamate dehydrogenase
(GLDH) served as a parameter for severe hepatocellular dam-
age (Hitachi 917 Rack, Roche Diagnostics, Mannheim, Ger-
many). Synthetic graft function was analyzed by continuous
measurement of bile production. Metabolic capability for
detoxification was determined by monoethylglycinexylidide-
test (MEGX) and galactose-elimination-rate (GE). MEGX pro-
duction was measured before and 30 minutes (180 min of
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reperfusion) after injection of lidocaine (1 mg/kg liver weight)
by fluorescence-polarisation-immunoassay (TDx/TDxFLx-
System, Abbott Diagnostics, Chicago, USA) (10–13). GE was
analyzed after 120 min of autologous reperfusion by spec-
trophotometric evaluation of concentration (NaF-plasma7D-
galactose DH UV-test, Roche Diagnostics, Mannheim, Ger-
many, spectrophotometer DU 7500, Beckmann Instruments
Inc., Fullerton, CA, USA). The concentration of D-galactose 
5 min after adding to perfusate the dose of 0.5 g/kg liver
weight was set as 100% value. The following concentrations
(15, 30, 60 min) were calculated as retention in percent (8). 
Experimental groups
Xenogeneic perfusion was stopped after 15 min, when he-
patic flow-rates deteriorated due to HXR. In group 1 (G1)
porcine livers were perfused with their own blood (autolo-
gous, control group). Pig livers of group 2 (G2) were perfused
with human blood without pre-treatment (xenogeneic). In
group 3 (G3), Ig-Therasorb® immunoapheresis was used for
depletion of XNAb (apheretic). After perfusion, all organs
were cold reflushed. Reperfusion of the organs was per-
formed with autologous blood for 5 hours. Values were ex-
pressed as means ± SD. Statistical differences were analyzed
by two-way repeated analysis of variance and by Student’s t-
test. They were considered significant at p < 0.05.
Results
Hemodynamics
In the first 30 min of autologous reperfusion, THP was
low in all groups. Subsequently, perfusion improved in
Fig. 2 Glutamate dehydrogenase (GLDH) activity in the stud-
ied groups. GLDH levels increased significantly in G2 (xeno-
geneic; ,) (*p<0.05). GLDH levels in G1 (control; d) and G3
(apheretic; j) were comparable.
Fig. 1 Total hepatic perfusion (THP) in the studied groups. At
the beginning of autologous reperfusion, THP was low in all
groups. In G1 (autologous; d) and G3 (apheretic; j) perfusion
recovered subsequently but not in G2 (xenogeneic; ,)
(*p<0.05).
Tab. 1 Bile production during autologous reperfusion.
Bile Time after Group 1 Group 2 Group 3
production reperfusion (autologous) (xenogeneic) (apheretic)
(µl/g liver/h) (min)
60 6.3 ± 1.8* 0.2 ± 0.1 0.6 ± 0.2
120 12.8 ± 2.8* 0.9 ± 0.2 1.4 ± 0.2
180 9.8 ± 1.8* 1.0 ± 0.2 1.9 ± 0.3
240 6.5 ± 1.7* 0.8 ± 0.1 1.2 ± 0.3
300 6.8 ± 1.7* 0.4 ± 0.1 1.0 ± 0.2
Mean ± SD are given; * p < 0.05 G1 vs. G2 and G3
Tab. 2 MEGX-production and galactose elimination rate during autologous reperfusion.
Galactose Time after Group 1 Group 2 Group 3
elimination reperfusion (autologous) (xenogeneic) (apheretic)
(Retention, %) (min)
Start 120 – – –
125 100 100 100
135 56.5 ± 4.2* 82.3 ± 5.6 76.5 ± 5.5
150 18.4 ± 4.8* 68.8 ± 4.6 64.6 ± 4.9
180 16.3 ± 3.8* 59.6 ± 3.9 55.9 ± 4.1
MEGX- 210 141 ± 18.5** 41.5 ± 8.9 84.7 ± 9.8***
production (µg/l)
Mean ± SE are given; * p < 0.05 G1 vs. G2 and G3, **p < 0.05 G1 vs. G2 and G3, 
***p < 0.05 G3 vs. G2
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the control group (G1) and the apheretic group (G3).
Autologous reperfusion did not lead to recovery of THP
in the xenogeneic group (*p<0.05) (Figure 1). 
Hepatocellular damage
There was a significant increase of the mitochondrial
GLDH level in G2, despite autologous reperfusion.
GLDH levels were not significantly different between
G1 (control) and G3 (apheretic) (Figure 2).
Liver function
Bile production of xenogeneic (G2) and apheretic (G3)
liver grafts was significantly lower during autologous
reperfusion (Table 1). 
While MEGX-production in G3 was still higher than
in G2, galactose elimination rate did not differ signifi-
cantly from xenogeneic grafts (Table 2).
Discussion
The increasing knowledge about the value of XNAb
and complement has led to several strategies to pro-
long experimental and clinical discordant xenogeneic
ECLP (3, 8). Terajima et al. reported xenogeneic pig
liver perfusion of 9 hours after administration of
prostaglandin E1 to the perfusate (5, 14). Immunoa-
pheresis has been demonstrated to delay HXR and
thus to improve perfusion (6). Just recently, Levy et al.
reported two patients with liver failure that were
bridged to transplantation by ECLP with transgeneic
organs (15). In all these cases, however, it still remains
speculative whether long-term ECLP is beneficial or
even harmful for the patient. We assumed the clinical
benefit to be very much dependent on the remaining
xenogeneic grafts’ metabolic capability during ECLP.
The results of our study demonstrate the harmful effect
of a short-term xenogeneic pig liver perfusion despite
autologous reperfusion. The application of IA resulted
in stable reperfusion but not in appropriate graft func-
tion. In the clinical situation, sufficient metabolic sup-
port and capability of detoxification is the main inten-
tion of ECLP. The ability to produce bile is one of the
most valid parameters of liver function (14, 16). In addi-
tion, MEGX formation has been shown to provide use-
ful prognostic values regarding experimental and clini-
cal liver graft survival (9, 13). MEGX formation is
mainly mediated by the microsomal cytochrome P-450
system by de-ethylation of lidocaine. Decrease in the
activity of this system is known to be associated with
hypoxic liver damage, which could be also a result of
endothelial disruption due to xenoreactive organ dam-
age (14, 16). Indeed, galactose elimination rate is a very
non-specific parameter of function; however, in our
study it confirmed the metabolic insufficiency of xeno-
geneic perfused grafts. 
For the clinical application of ECLP, measurement of
perfusion rates and release of aminotransferases are
not parameters with sufficient power to provide as-
sessment of the therapeutic course. In the future we
must focus on improving xenogeneic organ function,
rather than on pure prolongation of xenogeneic graft
perfusion. 
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